NeuroKaire Featured in OPEN MINDS: NeuroKaire Announces BrightKaire Blood Test To Reduce ‘Trial & Error’ Antidepressant Prescribing

OPEN MINDS covers NeuroKaire’s U.S. launch of BrightKaire™, a blood test designed to reduce trial-and-error antidepressant prescribing.